Clinical Trial for Advanced Bile Duct Cancer
0 意见
• 07/01/23
0
0
嵌入
Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论